QQ客服 官方微博 反馈留言

	Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study.
	Zhang Zhenxin; Wang Jian; Chen Shengdi; Liu Chunfeng; Zhang Baorong; Peng Rong; Sun Shenggang; Sun Xiangru; Zhao Gang; Qu Qiumin
刊名	Translational neurodegeneration
	2018
页码	32
关键词	China Monoamine oxidase inhibitor Monotherapy Parkinson’s disease Rasagiline
ISSN号	2047-9158
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1823329
专题	四川大学
作者单位	Peking Union Medical College Hospital, Beijing, China. 2Huashan Hospital, Fudan University, Shanghai, China. 3Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. 4The Second Affiliated Hospital of Soochow University, Suzhou, China. 5The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou China. 6West China Hospital, Sichuan University, Chengdu, China. 7Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China. 8Peking University First Hospital, Beijing, China. 9Xijing Hospital, The First Affiliated Hospital of The Fourth Military Medical University, Xi'an, China. 10The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. 11Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. 12Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China. 14The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. 15The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
推荐引用方式 GB/T 7714	Zhang Zhenxin,Wang Jian,Chen Shengdi,et al. Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study.[J]. Translational neurodegeneration,2018:32.
APA	Zhang Zhenxin.,Wang Jian.,Chen Shengdi.,Liu Chunfeng.,Zhang Baorong.,...&Wang Yanping.(2018).Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study..Translational neurodegeneration,32.
MLA	Zhang Zhenxin,et al."Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study.".Translational neurodegeneration (2018):32.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。